Identification of patients with pancreatic adenocarcinoma due to inheritable mutation: Challenges of daily clinical practice

Figure 1 Pancreatic Ductal Adenocarcinoma patient selection flow diagram: A total of 408 patients were screened; 400 patients were eligible. Six patients were excluded due to having diagnoses of other malignancies other than Pancreatic Ductal Adenocarcinoma; the remaining 2 patients excluded did not have a confirmed malignancy and were therefore excluded. n: Number of patients.

Figure 2 Flow diagram of patients’ suitability for referral using European Registry of Hereditary Pancreatitis and Familial Pancreatic Cancer criteria, along with referral outcome. DNA: Did not attend.